Organoid study links TGF-β signaling to astroglial activation in progranulin-related frontotemporal degeneration
Original source
TGF-β signaling promotes astroglial activation and TDP-43 proteinopathy in organoid models of frontotemporal lobar degeneration. (opens in a new tab)Compass summarised this from the study's abstract.
Study details
- Studied in
- Human, Mouse, Cells
Related topics
A study using laboratory-grown cortical organoids found that progranulin deficiency triggered early astroglial activation, neuronal stress and synaptic loss. The organoids also showed increased transforming growth factor beta (TGF-β) signaling and TDP-43 protein buildup in astrocytes. Blocking TGF-β signaling reduced these changes in the organoid models.
Why this matters
The findings identify a possible disease mechanism for progranulin-related frontotemporal lobar degeneration and provide a pathway for further research. They do not currently change treatment for people with ALS/MND or frontotemporal degeneration because the work was conducted in organoids, not people.
Limitations and context
This was laboratory research using induced pluripotent stem cell-derived cortical organoids with specific progranulin mutations. Organoids do not reproduce the full human brain or disease course, and the study did not test a treatment in patients or establish that blocking TGF-β is safe or effective in people. The source is a primary research report, not clinical evidence.